Adenocard Articles

Mechanism Of Action Proposed For Ribi's MPL-C

20 November 1995

Japan's Fujisawa Looks To 21 Century Growth

16 October 1995

Prospects For Glutamate Antagonists In Stroke

18 September 1995

Fujisawa gets order for Adenoscan

7 August 1995

UK Approval For Adenoscan

12 June 1995

Medco terminates Adenoscan agreement with Abbott

5 June 1995

Medco's Adenoscan Approved By FDA

29 May 1995

Medco's Adenoscan Approved By FDA

29 May 1995

Fujisawa USA/Medco Settle Adenoscan Lawsuits

29 May 1995

Celsis Sells Shares To Meet Development Cost

29 May 1995

Ares-Serono Announces Frone Efficacy Data In MS

14 November 1994

Phase III Results With H-R's Propentofylline

14 November 1994

Hoechst's Propentofylline Set For Spring '95 Filing

3 October 1994

ADA Gene Therapy Trial In Japan

26 September 1994

CellPro: Making Stem Cell Therapy A Reality

26 September 1994

Glaxo's Pipeline Update As Expected

19 September 1994

Gensia Halts Protara Trial On Panel Advice

22 August 1994

Hoechst-Roussel Drops Velnacrine

15 August 1994

MICROBIOLOGICAL ASSOCIATES EXPANDS

30 May 1994

HIGH CHOLESTEROL CORRECTED

11 April 1994

ENZON'S ONCASPAR APPROVED IN USA

14 February 1994

SANDOZ DEAL WITH NIPPON ZOKI

2 August 1993

US RESEARCH INTO CYSTIC FIBROSIS

12 July 1993

RHONE-POULENC RORER'S FOCUSED R&D PIPELINE

7 June 1993

FUJISAWA INELIGIBLE FOR FDA APPROVALS

17 May 1993

UK GENE THERAPY TRIAL APPROVED

1 February 1993

ZENECA'S PROMISING R&D PIPELINE PRESENTED

14 December 1992

SANYO-KOKUSAKU GOES INTO AIDS R&D

12 October 1992

MMD TO DEVELOP GENSIA COMPOUND

7 September 1992

ARASINE LEADING GENSIA PERFORMANCE

15 June 1992

FUJISAWA HIT BY JAPAN DRUG PRICING MOVES

1 June 1992

ALZHEIMER'S DISEASE: US CONCERN

27 January 1992

Showing 101-132 of 132 articles

Go to beginningPreviousNextGo to end